These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8066394)

  • 21. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.
    Presti JC; Hovey R; Carroll PR; Shinohara K
    J Urol; 1996 Nov; 156(5):1685-90. PubMed ID: 8863571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal, examination prostate specific antigen and the results of 6 systematic biopsies.
    Huland H; Hammerer P; Henke RP; Huland E
    J Urol; 1996 Apr; 155(4):1344-7. PubMed ID: 8632570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The digital rectal examination (DRE) remains important - outcomes from a contemporary cohort of men undergoing an initial 12-18 core prostate needle biopsy.
    Palmerola R; Smith P; Elliot V; Reese CT; Mahon FB; Harpster LE; Icitovic N; Raman JD
    Can J Urol; 2012 Dec; 19(6):6542-7. PubMed ID: 23228289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staging of prostate cancer. Accuracy of transrectal ultrasound enhanced by prostate-specific antigen.
    Wolf JS; Shinohara K; Narayan P
    Br J Urol; 1992 Nov; 70(5):534-41. PubMed ID: 1281724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison between 2 techniques of screening for prostatic carcinoma. Rectal exploration and transrectal ultrasonography vs. prostate specific antigen].
    Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M
    Radiol Med; 1994 Oct; 88(4):453-7. PubMed ID: 7527916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis of prostate cancer].
    Strittmatter F
    MMW Fortschr Med; 2010 May; 152(19):40-2. PubMed ID: 20557001
    [No Abstract]   [Full Text] [Related]  

  • 27. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
    Aus G
    Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T1c prostate cancer detection rate and pathologic characteristics: comparison between patients with serum prostate-specific antigen range of 3.0 to 4.0 ng/mL and 4.1 to 10.0 ng/mL in Korean population.
    Park HK; Hong SK; Byun SS; Lee SE
    Urology; 2006 Jul; 68(1):85-8. PubMed ID: 16806412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of cancer of the prostate. A study of 600 cases].
    Teillac P; Bron J; Tobolski F; Cussenot O; Lesourd A; Leroy M; Toubert ME; Brocheriou C; Laval-Jeantet M; Le Duc A
    Ann Urol (Paris); 1990; 24(1):37-41. PubMed ID: 1690963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Elements of the early diagnosis and staging of prostatic cancer. Functional results of radical surgery. Apropos of 50 complete prostatectomies].
    Lange D; Bruce W; Grellier P
    Ann Urol (Paris); 1990; 24(2):103-8. PubMed ID: 1693480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for prostate cancer.
    Pode D; Shapiro A; Lebensart P; Meretyk S; Katz G; Barak V
    Isr J Med Sci; 1995; 31(2-3):125-8. PubMed ID: 7538101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels.
    Ornstein DK; Rao GS; Smith DS; Ratliff TL; Basler JW; Catalona WJ
    J Urol; 1997 Jan; 157(1):195-8. PubMed ID: 8976249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of early-stage prostate cancer.
    Shore N
    Am J Manag Care; 2014 Dec; 20(12 Suppl):S260-72. PubMed ID: 25734965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cancer of the prostate: current diagnostic aspects].
    Sanz Velez JI; Gil Sanz MJ; Allepuz Losa C; Rioja Sanz LA
    Actas Urol Esp; 1991; 15(6):518-26. PubMed ID: 1724346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
    Stewart CS; Leibovich BC; Weaver AL; Lieber MM
    J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Circulating prostatic-specific antigen in benign hypertrophy and localized prostate cancer: can PSA be considered a screening examination for localized cancer?].
    Perrin P; Francois O; Maquet JH; Bringeon G; Duteil P; Devonec M
    Prog Urol; 1991 Jun; 1(3):419-31. PubMed ID: 1726943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1992 staging system for prostate cancer.
    Montie JE
    Semin Urol; 1993 Feb; 11(1):10-3. PubMed ID: 7682002
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnostic techniques in prostatic cancer.
    Drago JR
    Postgrad Med; 1986 Jul; 80(1):214-7, 220, 222-4. PubMed ID: 3523472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early diagnosis of cancer of the prostate. Is is useful?].
    Benítez Navío J; Arrizabalaga Moreno M; Delgado I; Casanueva Luis T; Gallardo Galán C
    Arch Esp Urol; 1990; 43 Suppl 1():81-95. PubMed ID: 2078069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.